nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.134	0.183	CbGbCtD
Flutamide—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.115	0.158	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0878	0.12	CbGbCtD
Flutamide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0806	0.11	CbGbCtD
Flutamide—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0645	0.0881	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0516	0.0704	CbGbCtD
Flutamide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.037	0.0505	CbGbCtD
Flutamide—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0339	0.0463	CbGbCtD
Flutamide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0338	0.0462	CbGbCtD
Flutamide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0314	0.0429	CbGbCtD
Flutamide—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0252	0.0345	CbGbCtD
Flutamide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0144	0.0197	CbGbCtD
Flutamide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0132	0.0181	CbGbCtD
Flutamide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00902	0.0123	CbGbCtD
Flutamide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000467	0.00175	CcSEcCtD
Flutamide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Flutamide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Flutamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Flutamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000459	0.00172	CcSEcCtD
Flutamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000459	0.00172	CcSEcCtD
Flutamide—Constipation—Topotecan—peripheral nervous system neoplasm	0.000459	0.00172	CcSEcCtD
Flutamide—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.00172	CcSEcCtD
Flutamide—Pulmonary embolism—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.00172	CcSEcCtD
Flutamide—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00171	CcSEcCtD
Flutamide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000457	0.00171	CcSEcCtD
Flutamide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000455	0.00171	CcSEcCtD
Flutamide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000455	0.00171	CcSEcCtD
Flutamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000453	0.0017	CcSEcCtD
Flutamide—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000449	0.00168	CcSEcCtD
Flutamide—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00168	CcSEcCtD
Flutamide—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00168	CcSEcCtD
Flutamide—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00168	CcSEcCtD
Flutamide—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.00168	CcSEcCtD
Flutamide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00167	CcSEcCtD
Flutamide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000442	0.00166	CcSEcCtD
Flutamide—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.00166	CcSEcCtD
Flutamide—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00044	0.00165	CcSEcCtD
Flutamide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000439	0.00164	CcSEcCtD
Flutamide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.00164	CcSEcCtD
Flutamide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000435	0.00163	CcSEcCtD
Flutamide—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.00162	CcSEcCtD
Flutamide—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.0016	CcSEcCtD
Flutamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000427	0.0016	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000426	0.0016	CcSEcCtD
Flutamide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00158	CcSEcCtD
Flutamide—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00042	0.00157	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.00157	CcSEcCtD
Flutamide—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.00156	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000415	0.00155	CcSEcCtD
Flutamide—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00155	CcSEcCtD
Flutamide—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00155	CcSEcCtD
Flutamide—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.00155	CcSEcCtD
Flutamide—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00155	CcSEcCtD
Flutamide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000411	0.00154	CcSEcCtD
Flutamide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00152	CcSEcCtD
Flutamide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.00151	CcSEcCtD
Flutamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00148	CcSEcCtD
Flutamide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00147	CcSEcCtD
Flutamide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00146	CcSEcCtD
Flutamide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000389	0.00146	CcSEcCtD
Flutamide—Oedema—Vincristine—peripheral nervous system neoplasm	0.000389	0.00146	CcSEcCtD
Flutamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000385	0.00144	CcSEcCtD
Flutamide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000385	0.00144	CcSEcCtD
Flutamide—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00144	CcSEcCtD
Flutamide—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000382	0.00143	CcSEcCtD
Flutamide—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00143	CcSEcCtD
Flutamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000382	0.00143	CcSEcCtD
Flutamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000382	0.00143	CcSEcCtD
Flutamide—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000381	0.00143	CcSEcCtD
Flutamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000381	0.00143	CcSEcCtD
Flutamide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00142	CcSEcCtD
Flutamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00038	0.00142	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000378	0.00142	CcSEcCtD
Flutamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00141	CcSEcCtD
Flutamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000377	0.00141	CcSEcCtD
Flutamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000377	0.00141	CcSEcCtD
Flutamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000377	0.00141	CcSEcCtD
Flutamide—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000376	0.00141	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00141	CcSEcCtD
Flutamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000372	0.00139	CcSEcCtD
Flutamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000371	0.00139	CcSEcCtD
Flutamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000367	0.00138	CcSEcCtD
Flutamide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00137	CcSEcCtD
Flutamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000364	0.00136	CcSEcCtD
Flutamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000364	0.00136	CcSEcCtD
Flutamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00036	0.00135	CcSEcCtD
Flutamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000359	0.00134	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000359	0.00134	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000358	0.00134	CcSEcCtD
Flutamide—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000357	0.00134	CcSEcCtD
Flutamide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000357	0.00134	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000356	0.00133	CcSEcCtD
Flutamide—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.00133	CcSEcCtD
Flutamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000355	0.00133	CcSEcCtD
Flutamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000354	0.00133	CcSEcCtD
Flutamide—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.00133	CcSEcCtD
Flutamide—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00132	CcSEcCtD
Flutamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000352	0.00132	CcSEcCtD
Flutamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000352	0.00132	CcSEcCtD
Flutamide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000352	0.00132	CcSEcCtD
Flutamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00131	CcSEcCtD
Flutamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000348	0.0013	CcSEcCtD
Flutamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.0013	CcSEcCtD
Flutamide—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.0013	CcSEcCtD
Flutamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000346	0.00129	CcSEcCtD
Flutamide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000345	0.00129	CcSEcCtD
Flutamide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000344	0.00129	CcSEcCtD
Flutamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000341	0.00128	CcSEcCtD
Flutamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000339	0.00127	CcSEcCtD
Flutamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000339	0.00127	CcSEcCtD
Flutamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000338	0.00127	CcSEcCtD
Flutamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000338	0.00127	CcSEcCtD
Flutamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000338	0.00127	CcSEcCtD
Flutamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000337	0.00126	CcSEcCtD
Flutamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000336	0.00126	CcSEcCtD
Flutamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000336	0.00126	CcSEcCtD
Flutamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000336	0.00126	CcSEcCtD
Flutamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000335	0.00126	CcSEcCtD
Flutamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000335	0.00126	CcSEcCtD
Flutamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000335	0.00126	CcSEcCtD
Flutamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000334	0.00125	CcSEcCtD
Flutamide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000334	0.00125	CcSEcCtD
Flutamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000334	0.00125	CcSEcCtD
Flutamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000334	0.00125	CcSEcCtD
Flutamide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000333	0.00125	CcSEcCtD
Flutamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.00125	CcSEcCtD
Flutamide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000333	0.00125	CcSEcCtD
Flutamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000331	0.00124	CcSEcCtD
Flutamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000331	0.00124	CcSEcCtD
Flutamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000328	0.00123	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000326	0.00122	CcSEcCtD
Flutamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000325	0.00122	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00121	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00121	CcSEcCtD
Flutamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000319	0.00119	CcSEcCtD
Flutamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000318	0.00119	CcSEcCtD
Flutamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000316	0.00118	CcSEcCtD
Flutamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000316	0.00118	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.00117	CcSEcCtD
Flutamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000312	0.00117	CcSEcCtD
Flutamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000308	0.00116	CcSEcCtD
Flutamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000306	0.00115	CcSEcCtD
Flutamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.0003	0.00112	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00112	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00112	CcSEcCtD
Flutamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00112	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00112	CcSEcCtD
Flutamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.00108	CcSEcCtD
Flutamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000286	0.00107	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00106	CcSEcCtD
Flutamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00106	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.00105	CcSEcCtD
Flutamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00028	0.00105	CcSEcCtD
Flutamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000279	0.00104	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00104	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000277	0.00104	CcSEcCtD
Flutamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00103	CcSEcCtD
Flutamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000274	0.00103	CcSEcCtD
Flutamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000274	0.00103	CcSEcCtD
Flutamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000272	0.00102	CcSEcCtD
Flutamide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00101	CcSEcCtD
Flutamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000269	0.00101	CcSEcCtD
Flutamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000999	CcSEcCtD
Flutamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000266	0.000996	CcSEcCtD
Flutamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000989	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000982	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00026	0.000972	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000971	CcSEcCtD
Flutamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.000968	CcSEcCtD
Flutamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000257	0.000963	CcSEcCtD
Flutamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.000961	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000959	CcSEcCtD
Flutamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.000953	CcSEcCtD
Flutamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.000952	CcSEcCtD
Flutamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000253	0.000947	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000935	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000931	CcSEcCtD
Flutamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000247	0.000926	CcSEcCtD
Flutamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000247	0.000924	CcSEcCtD
Flutamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000245	0.000918	CcSEcCtD
Flutamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000245	0.000917	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000917	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000915	CcSEcCtD
Flutamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000244	0.000912	CcSEcCtD
Flutamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.000898	CcSEcCtD
Flutamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000881	CcSEcCtD
Flutamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000231	0.000865	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000861	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000848	CcSEcCtD
Flutamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000226	0.000846	CcSEcCtD
Flutamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000223	0.000835	CcSEcCtD
Flutamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000819	CcSEcCtD
Flutamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000812	CcSEcCtD
Flutamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000811	CcSEcCtD
Flutamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00081	CcSEcCtD
Flutamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000216	0.000807	CcSEcCtD
Flutamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000795	CcSEcCtD
Flutamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000787	CcSEcCtD
Flutamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000208	0.00078	CcSEcCtD
Flutamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000765	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000752	CcSEcCtD
Flutamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0002	0.00075	CcSEcCtD
Flutamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00075	CcSEcCtD
Flutamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000749	CcSEcCtD
Flutamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000199	0.000744	CcSEcCtD
Flutamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000198	0.000743	CcSEcCtD
Flutamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000197	0.000739	CcSEcCtD
Flutamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000736	CcSEcCtD
Flutamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000731	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000728	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000725	CcSEcCtD
Flutamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000187	0.000701	CcSEcCtD
Flutamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000187	0.0007	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000696	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000693	CcSEcCtD
Flutamide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000687	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000685	CcSEcCtD
Flutamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000682	CcSEcCtD
Flutamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000676	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000671	CcSEcCtD
Flutamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000667	CcSEcCtD
Flutamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000661	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000648	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000647	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000642	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000636	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000634	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000631	CcSEcCtD
Flutamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00063	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000617	CcSEcCtD
Flutamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000612	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000599	CcSEcCtD
Flutamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000598	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000594	CcSEcCtD
Flutamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000588	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000583	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000575	CcSEcCtD
Flutamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00057	CcSEcCtD
Flutamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000566	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000553	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000545	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000544	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000532	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000528	CcSEcCtD
Flutamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000523	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000504	CcSEcCtD
Flutamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000474	CcSEcCtD
Flutamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000468	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000452	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000439	CcSEcCtD
Flutamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000437	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000433	CcSEcCtD
Flutamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00042	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000419	CcSEcCtD
Flutamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000417	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000417	CcSEcCtD
Flutamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000414	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000405	CcSEcCtD
Flutamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000393	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000389	CcSEcCtD
Flutamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000386	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000385	CcSEcCtD
Flutamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000383	CcSEcCtD
Flutamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.71e-05	0.000363	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	4.94e-05	0.102	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	3.09e-05	0.0636	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	1.91e-05	0.0393	CbGpPWpGaD
Flutamide—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	1.65e-05	0.0339	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	1.58e-05	0.0326	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	1.38e-05	0.0285	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	1.38e-05	0.0284	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—COX2—peripheral nervous system neoplasm	1.36e-05	0.0281	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.23e-05	0.0254	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.12e-05	0.023	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	1.05e-05	0.0215	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.04e-05	0.0214	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TH—peripheral nervous system neoplasm	1.01e-05	0.0207	CbGpPWpGaD
Flutamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	9.03e-06	0.0186	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	8.94e-06	0.0184	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	8.53e-06	0.0176	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.16e-06	0.0168	CbGpPWpGaD
Flutamide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	7.66e-06	0.0158	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	7.09e-06	0.0146	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	7.06e-06	0.0145	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	6.46e-06	0.0133	CbGpPWpGaD
Flutamide—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	6.4e-06	0.0132	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	5.45e-06	0.0112	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	5.44e-06	0.0112	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.14e-06	0.0106	CbGpPWpGaD
Flutamide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.95e-06	0.0102	CbGpPWpGaD
Flutamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	4.94e-06	0.0102	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	4.67e-06	0.00962	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	4.55e-06	0.00937	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.18e-06	0.0086	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	4.17e-06	0.00858	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—peripheral nervous system neoplasm	4.14e-06	0.00853	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	4.02e-06	0.00827	CbGpPWpGaD
Flutamide—AR—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	3.79e-06	0.0078	CbGpPWpGaD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.68e-06	0.00757	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.52e-06	0.00726	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.46e-06	0.00713	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	3.4e-06	0.00699	CbGpPWpGaD
Flutamide—AR—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	3.35e-06	0.00689	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	3.33e-06	0.00687	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.3e-06	0.00679	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.15e-06	0.0065	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	3.13e-06	0.00645	CbGpPWpGaD
Flutamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.98e-06	0.00613	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.91e-06	0.006	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.89e-06	0.00595	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	2.84e-06	0.00585	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.84e-06	0.00584	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.78e-06	0.00574	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.62e-06	0.0054	CbGpPWpGaD
Flutamide—AR—Gene Expression—EED—peripheral nervous system neoplasm	2.44e-06	0.00502	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.32e-06	0.00479	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2.29e-06	0.00472	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	2.26e-06	0.00465	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	2.24e-06	0.00461	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.17e-06	0.00447	CbGpPWpGaD
Flutamide—AR—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.95e-06	0.00401	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—AKT1—peripheral nervous system neoplasm	1.95e-06	0.00401	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.93e-06	0.00397	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.8e-06	0.0037	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.78e-06	0.00366	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.74e-06	0.00359	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.7e-06	0.00349	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.59e-06	0.00327	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.57e-06	0.00323	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	1.55e-06	0.0032	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.51e-06	0.00312	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.44e-06	0.00297	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—AKT1—peripheral nervous system neoplasm	1.44e-06	0.00296	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.43e-06	0.00295	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.41e-06	0.0029	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.38e-06	0.00285	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	1.36e-06	0.0028	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.3e-06	0.00269	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.23e-06	0.00253	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.17e-06	0.00241	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.14e-06	0.00236	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	1.13e-06	0.00234	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.13e-06	0.00232	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.12e-06	0.0023	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.09e-06	0.00224	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.05e-06	0.00216	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.02e-06	0.00211	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.67e-07	0.00199	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.43e-07	0.00194	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.25e-07	0.00191	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.12e-07	0.00188	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.99e-07	0.00185	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.03e-07	0.00165	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.91e-07	0.00163	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.81e-07	0.00161	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	7.4e-07	0.00152	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	7.09e-07	0.00146	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.04e-07	0.00145	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	6.99e-07	0.00144	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	6.88e-07	0.00142	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	6.83e-07	0.00141	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	6.7e-07	0.00138	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.57e-07	0.00135	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	6.45e-07	0.00133	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.16e-07	0.00127	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	5.81e-07	0.0012	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	5.72e-07	0.00118	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	5.59e-07	0.00115	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.54e-07	0.00114	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	5.48e-07	0.00113	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	5.46e-07	0.00112	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	5.28e-07	0.00109	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.12e-07	0.00106	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.76e-07	0.00098	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	4.48e-07	0.000923	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	4.46e-07	0.000918	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.46e-07	0.000918	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-07	0.000901	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	4.27e-07	0.00088	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	4.23e-07	0.000872	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	4.11e-07	0.000847	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	3.79e-07	0.00078	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.61e-07	0.000744	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.58e-07	0.000737	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	3.56e-07	0.000733	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	3.46e-07	0.000714	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.44e-07	0.000708	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.41e-07	0.000703	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	3.36e-07	0.000693	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.3e-07	0.000679	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.17e-07	0.000654	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.93e-07	0.000603	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	2.91e-07	0.000599	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	2.85e-07	0.000587	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.79e-07	0.000575	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.75e-07	0.000567	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.75e-07	0.000566	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.7e-07	0.000556	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.69e-07	0.000555	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—peripheral nervous system neoplasm	2.69e-07	0.000555	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.28e-07	0.00047	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.25e-07	0.000463	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.21e-07	0.000454	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.18e-07	0.000448	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	2.14e-07	0.000442	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.08e-07	0.000429	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—peripheral nervous system neoplasm	1.87e-07	0.000385	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.76e-07	0.000363	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.75e-07	0.000361	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.72e-07	0.000354	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.68e-07	0.000346	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.66e-07	0.000341	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-07	0.000278	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.33e-07	0.000273	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-07	0.000248	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	7.85e-08	0.000162	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	7.41e-08	0.000153	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	6.07e-08	0.000125	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.73e-08	9.73e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.65e-08	7.51e-05	CbGpPWpGaD
